基于转录因子的多能干细胞分化:克服随机神经元命运的陷
Georgie McDaid1, Jaime Vanek1, Brett Cromer1
1Department of Chemistry and Biotechnology, Swinburne University of Technology, Melbourne, VIC 3122, Australia.
Biomedicines
|November 27, 2025
概括
基于转录因子的方法能够精确地将多能干细胞分化为多种神经亚型,从而推进神经科学研究和疾病建模. 这种方法克服了创建复杂大脑模型的传统方法的局限性.
科学领域:
- 神经科学是一个神经科学.
- 干细胞生物学 干细胞生物学
- 发展生物学 发展生物学
背景情况:
- 目前用于分化多能干细胞 (PSC) 的方法主要产生激发性神经元,缺乏关键的抑制性内神经元和微质细胞等质细胞.
- 由于血统的局限性,传统的与星体细胞共同培养系统无法完全回顾大脑的细胞复杂性.
- 对神经元生理学和大脑复杂性的准确建模需要结合各种神经子类型.
研究的目的:
- 审查基于转录因子的体外分化策略的最新进展,以从PSC产生多样化的神经群体.
- 突出控制差异化的优点,以创建更准确和可复制的体外大脑模型.
- 讨论在将这些方法转化为临床相关性的剩余挑战.
主要方法:
- 使用基于转录因子的策略,以对PSC进行定向的体外分化.
- 产生特定的神经元亚型,包括抑制性内部神经元和质细胞.
- 在2D/3D培养物和有机物中开发精确的播种和比率建立的受控分化协议.
主要成果:
- 基于转录因子的方法可以快速和可控地产生高度特定的神经细胞类型.
- 这种方法有助于创建更准确和可复制的体外模型,包括有机体.
- 控制差异化超越了从神经元原生细胞随机差异化的局限性.
结论:
- 基于转录因子的差异化为产生多样化的神经子类型提供了一个强大的工具,这对于先进的神经科学研究至关重要.
- 这些方法允许创建复杂的体外模型,用于疾病建模和再生医学.
- 解决复制性和表型成熟等挑战是临床翻译的关键.
相关概念视频
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Induced Pluripotent Stem Cells
27.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K
Forced Transdifferentiation
2.3K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.3K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K


